| Price of cancer drugs varies by up to 388% between European countries, Australia, and New Zealand Related items from OnMedica Plans to change next year’s National Tariff for NHS services face setback Most clinicians back moves to make pharma industry ties more transparent NHS cash pressures causing bad rationing decisions Cancer drug access in England is a ‘debacle’ The medicine price debate |
No comments:
Post a Comment